Effect of Difelikefalin, a Selective Kappa Opioid Receptor Agonist, on Respiratory Depression: A Randomized, Double-Blind, Placebo-Controlled Trial
Synopsis
Dr. Beatrice Setnik, Chief Scientific Officer at Altasciences, contributes to the results and findings from a central nervous system (CNS) study.
URL
https://ascpt.onlinelibrary.wiley.com/doi/10.1111/cts.13042
Date of publication
May 12, 2021
Category